Conference item : Abstract
Efficacy and safety of switching from adalimumab to baricitinib: phase 3 data in patients with rheumatoid arthritis
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Journal of Rheumatology Publisher's website
- Host title:
- Journal of Rheumatology
- Journal:
- Journal of Rheumatology Journal website
- Volume:
- 44
- Issue:
- 6
- Pages:
- 890-891
- Publication date:
- 2017-06-01
- Acceptance date:
- 2016-12-15
- DOI:
- EISSN:
-
1499-2752
- ISSN:
-
0315-162X
Item Description
- Subtype:
- Abstract
- Pubs id:
-
pubs:715669
- UUID:
-
uuid:0cc26971-653f-49e2-bddb-b20f03f2d0d5
- Local pid:
- pubs:715669
- Source identifiers:
-
715669
- Deposit date:
- 2019-02-13
Terms of use
- Copyright holder:
- Taylor et al
- Copyright date:
- 2017
- Notes:
-
Presented at the Canadian Rheumatology Association Meeting, The Westin Ottawa
Ottawa, Ontario, Canada, February 8-11, 2017.
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record